SCHEMBL4738893

SCHEMBL4738893

C[C@@H](CCc1ccc2c(cnn2-c2cncnc2)c1)NC(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SMO Q99835 18/20 0.47
NR3C1 P04150 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4784046 0.88 SMO (0.57) SMONR3C1
SCHEMBL4735199 0.77 NR3C1 (0.40) SMONR3C1
SCHEMBL4737072 0.76 SMO (0.42) SMO
SCHEMBL4736966 0.73 NR3C1 (0.58) NR3C1
SCHEMBL4784906 0.72 NR3C1 (0.49) SMONR3C1
SCHEMBL4738899 0.72 DYRK1A (0.45)
SCHEMBL27721784 0.70 NR3C1 (0.56) NR3C1
SCHEMBL4123094 0.70 NR3C1 (0.56) NR3C1
SCHEMBL995999 0.69 LIPG (0.45)
SCHEMBL21591549 0.69 LMNA (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008079073-A1 INDAZOLYL SULPHONAMIDE DERIVATIVES FOR THE TREATMENT OF GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS ASTRAZENECA AB (SE) 2008-07-03 WO disclosed